BUILD-IN PAGE COMPOSER

Rising medical costs and shifting health drivers fuel innovation in employer-sponsored health plans Medical costs continue to outpace general inflation by close to three times, with a global average 9.7% in 2018 with similar increases for 2019 and 2020, according to the Mercer Marsh Benefits (MMB) 2019 Medical Trends Around the World report, released in June 2019. A survey of 204 insurers across 59 countries, the report assesses how

TRAVEL

BEAUTY

HIPSTER

Latest Posts

MAXIS Global Benefits Network (MAXIS GBN) in May 2020 announced that AXA COLPATRIA had joined the London-based global employee benefits network. AXA COLPATRIA provides medical coverage in Colombia as prepaid and health insurance. It is headed by Bernardo Rafael Serrano López, General Director and CEO. The company claims to be the sixth largest carrier in the Colombian PHI sector (pre-hospital and insurance) with a 6% market share and 220,000

In early 2020, it seemed like people with diabetes were disproportionately dying with COVID-19, but the data provided more questions than answers. What type of diabetes did people have? Were people dying because the condition itself put them at greater risk, or because those with it tend to be older and have other illnesses? And what should people with diabetes do to protect themselves?

Many countries are moving to exit a lockdown triggered by COVID-19, but the virus has not gone away and there are real concerns that a second wave of infection could happen. We urgently need to understand more about how the body deals with this infection and what we can do to tackle it. Immunology has taken centre stage here in revealing what happens when our body fights this virus, and brings us the possibility of treatments and vaccines.

Some people question why the current coronavirus has brought the world to standstill while a previous deadly coronavirus, SARS, did not. Others have questioned why a vaccine is so urgently needed now to stop the spread of the current coronavirus when a vaccine was never developed for SARS.
SHARE

Sample Home 1